Empagliflozin
Free Delivery
Lorem Ipsum dummy
Big Savings
Lorem Ipsum dummy
Customer Care
Lorem Ipsum dummy
Gift Voucher
Lorem Ipsum dummy
Active Ingredient: Empagliflozin
Therapeutic Class: SGLT2 Inhibitor
Indications: Type 2 diabetes, chronic heart failure, kidney disease
Dosage Form: Tablets (10mg, 25mg)
Manufacturer: Boehringer Ingelheim (Germany) / Eli Lilly (USA)
Administration Advice: Taken once daily with or without food; monitor kidney function
Certification / Approval Status: Approved in 130+ countries, including the US, EU, and Canada
Special Notes: Also shown to reduce cardiovascular and renal risk

Add to cart
Sold out
- Choosing a selection results in a full page refresh.